🔎 Trials Near Me

Home › Multiple Sclerosis › Arizona

Pag-aaral pangklinika para sa Multiple Sclerosis sa Arizona

6 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Arizona.

Mga Lungsod sa Arizona

Opisyal na teksto ng pag-aaral (English)

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Arizona, Tucson
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07002034

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Gilbert
  • TG Therapeutics Investigational Trial Site, Phoenix
  • TG Therapeutics Investigational Trial Site, Scottsdale
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06433752

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

  • Clinical Endpoints, LLC, Scottsdale
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07609719

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Perseverance Research Center,LLC, Scottsdale
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06782490

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195, Phoenix
  • Perseverance Research Center- Site Number : 8400138, Scottsdale
  • Center for Neurosciences - Tucson- Site Number : 8400194, Tucson
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07325292

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Xenoscience Inc, Phoenix
  • Ctr for Neurology and Spine, Phoenix
  • AZ Integrated Neuro and Spine, Phoenix
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07225504

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.